June Almenoff
2013
In 2013, June Almenoff earned a total compensation of $180.2K as Director at Ohr Pharmaceutical.
Compensation breakdown
| Option Awards | $180,157 |
|---|---|
| Total | $180,157 |
Almenoff received $180.2K in option awards, accounting for 100% of the total pay in 2013.
Rankings
In 2013, June Almenoff's compensation ranked 11,737th out of 12,286 executives tracked by ExecPay. In other words, Almenoff earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,737 out of 12,286 | 5th |
Division Manufacturing | 4,397 out of 4,612 | 5th |
Major group Chemicals And Allied Products | 1,395 out of 1,466 | 5th |
Industry group Drugs | 1,109 out of 1,160 | 4th |
Industry Pharmaceutical Preparations | 855 out of 890 | 4th |
Source: SEC filing on March 7, 2014.
Almenoff's colleagues
We found five more compensation records of executives who worked with June Almenoff at Ohr Pharmaceutical in 2013.